D.n.a.; Intellectual Property; Exclusive Rights; Synthetic C.d.n.a.; Products of Nature; Patent Law; Medical Research; Science and Technology; Patents; Human Genes
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013).
https://www.govinfo.gov/app/details/USREPORTS-569/USREPORTS-569-576.
APA
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013).
https://www.govinfo.gov/app/details/USREPORTS-569/USREPORTS-569-576.
MLA
United States, Supreme Court. Association for Molecular Pathology v. Myriad Genetics, Inc.. United States Reports, vol. 569, 13 June 2013, p. 576. U.S. Government Publishing Office.
https://www.govinfo.gov/app/details/USREPORTS-569/USREPORTS-569-576.
Bluebook
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013).